instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Long-term Use of Golimumab in Daily Practice for Patients with Rheumatoid Arthritis.
Objective To evaluate the effectiveness and drug retention rate of golimumab (GLM) for long-term use in daily practice for patients with rheumatoid arthritis (RA). Methods Patients with RA who started GLM therapy with a minimum follow-... | ABATACEPT, ACTARIT, ADALIMUMAB, BUCILLAMINE, ETANERCEPT, GOLIMUMAB, IGURATIMOD, INFLIXIMAB, METHOTREXATE, MIZORIBINE, PREDNISOLONE, SULFASALAZINE, TACROLIMUS, TOCILIZUMAB | DrugsGivenReaction | CC BY-NC-ND | 33250460 | 18,599,924 | 2021-05-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Eczema'. | Long-term Use of Golimumab in Daily Practice for Patients with Rheumatoid Arthritis.
Objective To evaluate the effectiveness and drug retention rate of golimumab (GLM) for long-term use in daily practice for patients with rheumatoid arthritis (RA). Methods Patients with RA who started GLM therapy with a minimum follow-... | ABATACEPT, ACTARIT, ADALIMUMAB, BUCILLAMINE, ETANERCEPT, GOLIMUMAB, IGURATIMOD, INFLIXIMAB, METHOTREXATE, MIZORIBINE, PREDNISOLONE, SULFASALAZINE, TACROLIMUS, TOCILIZUMAB | DrugsGivenReaction | CC BY-NC-ND | 33250460 | 18,599,924 | 2021-05-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Infection'. | Long-term Use of Golimumab in Daily Practice for Patients with Rheumatoid Arthritis.
Objective To evaluate the effectiveness and drug retention rate of golimumab (GLM) for long-term use in daily practice for patients with rheumatoid arthritis (RA). Methods Patients with RA who started GLM therapy with a minimum follow-... | ABATACEPT, ACTARIT, ADALIMUMAB, BUCILLAMINE, ETANERCEPT, GOLIMUMAB, IGURATIMOD, INFLIXIMAB, METHOTREXATE, MIZORIBINE, PREDNISOLONE, SULFASALAZINE, TACROLIMUS, TOCILIZUMAB | DrugsGivenReaction | CC BY-NC-ND | 33250460 | 18,599,924 | 2021-05-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Multiple sclerosis'. | Long-term Use of Golimumab in Daily Practice for Patients with Rheumatoid Arthritis.
Objective To evaluate the effectiveness and drug retention rate of golimumab (GLM) for long-term use in daily practice for patients with rheumatoid arthritis (RA). Methods Patients with RA who started GLM therapy with a minimum follow-... | ABATACEPT, ACTARIT, ADALIMUMAB, BUCILLAMINE, ETANERCEPT, GOLIMUMAB, IGURATIMOD, INFLIXIMAB, METHOTREXATE, MIZORIBINE, PREDNISOLONE, SULFASALAZINE, TACROLIMUS, TOCILIZUMAB | DrugsGivenReaction | CC BY-NC-ND | 33250460 | 18,599,924 | 2021-05-01 |
What was the administration route of drug 'GOLIMUMAB'? | Long-term Use of Golimumab in Daily Practice for Patients with Rheumatoid Arthritis.
Objective To evaluate the effectiveness and drug retention rate of golimumab (GLM) for long-term use in daily practice for patients with rheumatoid arthritis (RA). Methods Patients with RA who started GLM therapy with a minimum follow-... | Subcutaneous | DrugAdministrationRoute | CC BY-NC-ND | 33250460 | 18,599,924 | 2021-05-01 |
What was the dosage of drug 'METHOTREXATE'? | Long-term Use of Golimumab in Daily Practice for Patients with Rheumatoid Arthritis.
Objective To evaluate the effectiveness and drug retention rate of golimumab (GLM) for long-term use in daily practice for patients with rheumatoid arthritis (RA). Methods Patients with RA who started GLM therapy with a minimum follow-... | 8 mg (milligrams). | DrugDosage | CC BY-NC-ND | 33250460 | 18,599,924 | 2021-05-01 |
What was the dosage of drug 'PREDNISOLONE'? | Long-term Use of Golimumab in Daily Practice for Patients with Rheumatoid Arthritis.
Objective To evaluate the effectiveness and drug retention rate of golimumab (GLM) for long-term use in daily practice for patients with rheumatoid arthritis (RA). Methods Patients with RA who started GLM therapy with a minimum follow-... | 3 mg (milligrams). | DrugDosage | CC BY-NC-ND | 33250460 | 18,599,924 | 2021-05-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Diabetes mellitus'. | Clinical Characteristics and Treatment Response With Checkpoint Inhibitors in Malignant Melanoma of the Vulva and Vagina.
OBJECTIVE
The aims of the study were to assess the clinical and histopathological characteristics of a comprehensive cohort of women with vulvovaginal melanoma (VVM) treated at our institution and t... | IPILIMUMAB, PEMBROLIZUMAB | DrugsGivenReaction | CC BY | 33252450 | 18,648,560 | 2021-04-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Erythema nodosum'. | Clinical Characteristics and Treatment Response With Checkpoint Inhibitors in Malignant Melanoma of the Vulva and Vagina.
OBJECTIVE
The aims of the study were to assess the clinical and histopathological characteristics of a comprehensive cohort of women with vulvovaginal melanoma (VVM) treated at our institution and t... | IPILIMUMAB, PEMBROLIZUMAB | DrugsGivenReaction | CC BY | 33252450 | 18,648,560 | 2021-04-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Immune-mediated hyperthyroidism'. | Clinical Characteristics and Treatment Response With Checkpoint Inhibitors in Malignant Melanoma of the Vulva and Vagina.
OBJECTIVE
The aims of the study were to assess the clinical and histopathological characteristics of a comprehensive cohort of women with vulvovaginal melanoma (VVM) treated at our institution and t... | IPILIMUMAB, PEMBROLIZUMAB | DrugsGivenReaction | CC BY | 33252450 | 18,648,560 | 2021-04-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective for unapproved indication'. | Fatal Case of Chronic Jamestown Canyon Virus Encephalitis Diagnosed by Metagenomic Sequencing in Patient Receiving Rituximab.
A 56-year-old man receiving rituximab who had months of neurologic symptoms was found to have Jamestown Canyon virus in cerebrospinal fluid by clinical metagenomic sequencing. The patient died, ... | FAVIPIRAVIR, HUMAN IMMUNOGLOBULIN G, RITUXIMAB | DrugsGivenReaction | CC BY | 33261720 | 19,026,565 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Fatal Case of Chronic Jamestown Canyon Virus Encephalitis Diagnosed by Metagenomic Sequencing in Patient Receiving Rituximab.
A 56-year-old man receiving rituximab who had months of neurologic symptoms was found to have Jamestown Canyon virus in cerebrospinal fluid by clinical metagenomic sequencing. The patient died, ... | FAVIPIRAVIR, HUMAN IMMUNOGLOBULIN G, RITUXIMAB | DrugsGivenReaction | CC BY | 33261720 | 19,026,565 | 2021-01 |
What was the administration route of drug 'HUMAN IMMUNOGLOBULIN G'? | Fatal Case of Chronic Jamestown Canyon Virus Encephalitis Diagnosed by Metagenomic Sequencing in Patient Receiving Rituximab.
A 56-year-old man receiving rituximab who had months of neurologic symptoms was found to have Jamestown Canyon virus in cerebrospinal fluid by clinical metagenomic sequencing. The patient died, ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33261720 | 19,026,565 | 2021-01 |
What was the dosage of drug 'HUMAN IMMUNOGLOBULIN G'? | Fatal Case of Chronic Jamestown Canyon Virus Encephalitis Diagnosed by Metagenomic Sequencing in Patient Receiving Rituximab.
A 56-year-old man receiving rituximab who had months of neurologic symptoms was found to have Jamestown Canyon virus in cerebrospinal fluid by clinical metagenomic sequencing. The patient died, ... | 2 GRAM PER KILOGRAM | DrugDosageText | CC BY | 33261720 | 19,026,565 | 2021-01 |
What was the outcome of reaction 'Drug ineffective for unapproved indication'? | Fatal Case of Chronic Jamestown Canyon Virus Encephalitis Diagnosed by Metagenomic Sequencing in Patient Receiving Rituximab.
A 56-year-old man receiving rituximab who had months of neurologic symptoms was found to have Jamestown Canyon virus in cerebrospinal fluid by clinical metagenomic sequencing. The patient died, ... | Fatal | ReactionOutcome | CC BY | 33261720 | 19,026,565 | 2021-01 |
What was the outcome of reaction 'Off label use'? | Fatal Case of Chronic Jamestown Canyon Virus Encephalitis Diagnosed by Metagenomic Sequencing in Patient Receiving Rituximab.
A 56-year-old man receiving rituximab who had months of neurologic symptoms was found to have Jamestown Canyon virus in cerebrospinal fluid by clinical metagenomic sequencing. The patient died, ... | Fatal | ReactionOutcome | CC BY | 33261720 | 19,026,565 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acquired chromosomal abnormality'. | Copy number evolution and its relationship with patient outcome-an analysis of 178 matched presentation-relapse tumor pairs from the Myeloma XI trial.
Structural chromosomal changes including copy number aberrations (CNAs) are a major feature of multiple myeloma (MM), however their evolution in context of modern biolog... | CARFILZOMIB, CYCLOPHOSPHAMIDE, DEXAMETHASONE | DrugsGivenReaction | CC BY | 33262523 | 20,436,778 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Death'. | Copy number evolution and its relationship with patient outcome-an analysis of 178 matched presentation-relapse tumor pairs from the Myeloma XI trial.
Structural chromosomal changes including copy number aberrations (CNAs) are a major feature of multiple myeloma (MM), however their evolution in context of modern biolog... | CARFILZOMIB, CYCLOPHOSPHAMIDE, DEXAMETHASONE | DrugsGivenReaction | CC BY | 33262523 | 20,436,778 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Plasma cell myeloma'. | Copy number evolution and its relationship with patient outcome-an analysis of 178 matched presentation-relapse tumor pairs from the Myeloma XI trial.
Structural chromosomal changes including copy number aberrations (CNAs) are a major feature of multiple myeloma (MM), however their evolution in context of modern biolog... | CARFILZOMIB, CYCLOPHOSPHAMIDE, DEXAMETHASONE | DrugsGivenReaction | CC BY | 33262523 | 20,436,778 | 2021-07 |
What was the outcome of reaction 'Death'? | Copy number evolution and its relationship with patient outcome-an analysis of 178 matched presentation-relapse tumor pairs from the Myeloma XI trial.
Structural chromosomal changes including copy number aberrations (CNAs) are a major feature of multiple myeloma (MM), however their evolution in context of modern biolog... | Fatal | ReactionOutcome | CC BY | 33262523 | 20,436,778 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Exposure during pregnancy'. | Use of dexamethasone, remdesivir, convalescent plasma and prone positioning in the treatment of severe COVID-19 infection in pregnancy: A case report.
Severe infection with COVID-19 virus in pregnancy offers unique management challenges for the obstetrician and critical care specialist. We report the case of a woman at... | AZITHROMYCIN ANHYDROUS, CEFTRIAXONE, DEXAMETHASONE, ENOXAPARIN, HEPARIN SODIUM, REMDESIVIR | DrugsGivenReaction | CC BY-NC-ND | 33262932 | 18,730,194 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Use of dexamethasone, remdesivir, convalescent plasma and prone positioning in the treatment of severe COVID-19 infection in pregnancy: A case report.
Severe infection with COVID-19 virus in pregnancy offers unique management challenges for the obstetrician and critical care specialist. We report the case of a woman at... | AZITHROMYCIN ANHYDROUS, CEFTRIAXONE, DEXAMETHASONE, ENOXAPARIN, FUROSEMIDE, HEPARIN SODIUM, INSULIN NOS, REMDESIVIR | DrugsGivenReaction | CC BY-NC-ND | 33262932 | 18,868,538 | 2021-01 |
What is the weight of the patient? | Use of dexamethasone, remdesivir, convalescent plasma and prone positioning in the treatment of severe COVID-19 infection in pregnancy: A case report.
Severe infection with COVID-19 virus in pregnancy offers unique management challenges for the obstetrician and critical care specialist. We report the case of a woman at... | 1.31 kg. | Weight | CC BY-NC-ND | 33262932 | 18,703,859 | 2021-01 |
What was the administration route of drug 'AZITHROMYCIN ANHYDROUS'? | Use of dexamethasone, remdesivir, convalescent plasma and prone positioning in the treatment of severe COVID-19 infection in pregnancy: A case report.
Severe infection with COVID-19 virus in pregnancy offers unique management challenges for the obstetrician and critical care specialist. We report the case of a woman at... | Transplacental | DrugAdministrationRoute | CC BY-NC-ND | 33262932 | 18,831,127 | 2021-01 |
What was the administration route of drug 'CEFTRIAXONE'? | Use of dexamethasone, remdesivir, convalescent plasma and prone positioning in the treatment of severe COVID-19 infection in pregnancy: A case report.
Severe infection with COVID-19 virus in pregnancy offers unique management challenges for the obstetrician and critical care specialist. We report the case of a woman at... | Transplacental | DrugAdministrationRoute | CC BY-NC-ND | 33262932 | 18,831,127 | 2021-01 |
What was the administration route of drug 'ENOXAPARIN'? | Use of dexamethasone, remdesivir, convalescent plasma and prone positioning in the treatment of severe COVID-19 infection in pregnancy: A case report.
Severe infection with COVID-19 virus in pregnancy offers unique management challenges for the obstetrician and critical care specialist. We report the case of a woman at... | Transplacental | DrugAdministrationRoute | CC BY-NC-ND | 33262932 | 18,730,438 | 2021-01 |
What was the administration route of drug 'FUROSEMIDE'? | Use of dexamethasone, remdesivir, convalescent plasma and prone positioning in the treatment of severe COVID-19 infection in pregnancy: A case report.
Severe infection with COVID-19 virus in pregnancy offers unique management challenges for the obstetrician and critical care specialist. We report the case of a woman at... | Transplacental | DrugAdministrationRoute | CC BY-NC-ND | 33262932 | 18,831,127 | 2021-01 |
What was the administration route of drug 'HEPARIN SODIUM'? | Use of dexamethasone, remdesivir, convalescent plasma and prone positioning in the treatment of severe COVID-19 infection in pregnancy: A case report.
Severe infection with COVID-19 virus in pregnancy offers unique management challenges for the obstetrician and critical care specialist. We report the case of a woman at... | Transplacental | DrugAdministrationRoute | CC BY-NC-ND | 33262932 | 18,730,438 | 2021-01 |
What was the administration route of drug 'INSULIN NOS'? | Use of dexamethasone, remdesivir, convalescent plasma and prone positioning in the treatment of severe COVID-19 infection in pregnancy: A case report.
Severe infection with COVID-19 virus in pregnancy offers unique management challenges for the obstetrician and critical care specialist. We report the case of a woman at... | Transplacental | DrugAdministrationRoute | CC BY-NC-ND | 33262932 | 18,831,127 | 2021-01 |
What was the administration route of drug 'OXYGEN'? | Use of dexamethasone, remdesivir, convalescent plasma and prone positioning in the treatment of severe COVID-19 infection in pregnancy: A case report.
Severe infection with COVID-19 virus in pregnancy offers unique management challenges for the obstetrician and critical care specialist. We report the case of a woman at... | Transplacental | DrugAdministrationRoute | CC BY-NC-ND | 33262932 | 18,831,127 | 2021-01 |
What was the administration route of drug 'REMDESIVIR'? | Use of dexamethasone, remdesivir, convalescent plasma and prone positioning in the treatment of severe COVID-19 infection in pregnancy: A case report.
Severe infection with COVID-19 virus in pregnancy offers unique management challenges for the obstetrician and critical care specialist. We report the case of a woman at... | Transplacental | DrugAdministrationRoute | CC BY-NC-ND | 33262932 | 18,831,127 | 2021-01 |
What was the dosage of drug 'FUROSEMIDE'? | Use of dexamethasone, remdesivir, convalescent plasma and prone positioning in the treatment of severe COVID-19 infection in pregnancy: A case report.
Severe infection with COVID-19 virus in pregnancy offers unique management challenges for the obstetrician and critical care specialist. We report the case of a woman at... | MATERNAL DOSE ?UNK | DrugDosageText | CC BY-NC-ND | 33262932 | 18,707,918 | 2021-01 |
What was the dosage of drug 'INSULIN NOS'? | Use of dexamethasone, remdesivir, convalescent plasma and prone positioning in the treatment of severe COVID-19 infection in pregnancy: A case report.
Severe infection with COVID-19 virus in pregnancy offers unique management challenges for the obstetrician and critical care specialist. We report the case of a woman at... | MATERNAL DOSE: UNK | DrugDosageText | CC BY-NC-ND | 33262932 | 18,707,918 | 2021-01 |
What was the outcome of reaction 'Adrenal insufficiency'? | Use of dexamethasone, remdesivir, convalescent plasma and prone positioning in the treatment of severe COVID-19 infection in pregnancy: A case report.
Severe infection with COVID-19 virus in pregnancy offers unique management challenges for the obstetrician and critical care specialist. We report the case of a woman at... | Recovered | ReactionOutcome | CC BY-NC-ND | 33262932 | 18,730,438 | 2021-01 |
What was the outcome of reaction 'Exposure during pregnancy'? | Use of dexamethasone, remdesivir, convalescent plasma and prone positioning in the treatment of severe COVID-19 infection in pregnancy: A case report.
Severe infection with COVID-19 virus in pregnancy offers unique management challenges for the obstetrician and critical care specialist. We report the case of a woman at... | Recovered | ReactionOutcome | CC BY-NC-ND | 33262932 | 18,730,194 | 2021-01 |
What was the outcome of reaction 'Foetal exposure during pregnancy'? | Use of dexamethasone, remdesivir, convalescent plasma and prone positioning in the treatment of severe COVID-19 infection in pregnancy: A case report.
Severe infection with COVID-19 virus in pregnancy offers unique management challenges for the obstetrician and critical care specialist. We report the case of a woman at... | Recovered | ReactionOutcome | CC BY-NC-ND | 33262932 | 18,730,438 | 2021-01 |
What was the outcome of reaction 'Hyperglycaemia'? | Use of dexamethasone, remdesivir, convalescent plasma and prone positioning in the treatment of severe COVID-19 infection in pregnancy: A case report.
Severe infection with COVID-19 virus in pregnancy offers unique management challenges for the obstetrician and critical care specialist. We report the case of a woman at... | Recovered | ReactionOutcome | CC BY-NC-ND | 33262932 | 18,730,194 | 2021-01 |
What was the outcome of reaction 'Premature baby'? | Use of dexamethasone, remdesivir, convalescent plasma and prone positioning in the treatment of severe COVID-19 infection in pregnancy: A case report.
Severe infection with COVID-19 virus in pregnancy offers unique management challenges for the obstetrician and critical care specialist. We report the case of a woman at... | Recovered | ReactionOutcome | CC BY-NC-ND | 33262932 | 18,621,424 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Adverse event'. | Effect of Sex in Systemic Psoriasis Therapy: Differences in Prescription, Effectiveness and Safety in the BIOBADADERM Prospective Cohort.
The effect of sex on systemic therapy for psoriasis has not been well studied. The aim of this study was to analyse a large multicentre Spanish cohort of 2,881 patients with psoriasi... | ADALIMUMAB, APREMILAST, CYCLOSPORINE, INFLIXIMAB, IXEKIZUMAB, METHOTREXATE, SECUKINUMAB, USTEKINUMAB | DrugsGivenReaction | CC BY-NC | 33269405 | 18,973,641 | 2021-01-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Angiopathy'. | Effect of Sex in Systemic Psoriasis Therapy: Differences in Prescription, Effectiveness and Safety in the BIOBADADERM Prospective Cohort.
The effect of sex on systemic therapy for psoriasis has not been well studied. The aim of this study was to analyse a large multicentre Spanish cohort of 2,881 patients with psoriasi... | ADALIMUMAB, APREMILAST, CYCLOSPORINE, INFLIXIMAB, IXEKIZUMAB, METHOTREXATE, SECUKINUMAB, USTEKINUMAB | DrugsGivenReaction | CC BY-NC | 33269405 | 18,973,641 | 2021-01-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Benign neoplasm'. | Effect of Sex in Systemic Psoriasis Therapy: Differences in Prescription, Effectiveness and Safety in the BIOBADADERM Prospective Cohort.
The effect of sex on systemic therapy for psoriasis has not been well studied. The aim of this study was to analyse a large multicentre Spanish cohort of 2,881 patients with psoriasi... | ADALIMUMAB, APREMILAST, CYCLOSPORINE, INFLIXIMAB, IXEKIZUMAB, METHOTREXATE, SECUKINUMAB, USTEKINUMAB | DrugsGivenReaction | CC BY-NC | 33269405 | 18,973,641 | 2021-01-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Blood disorder'. | Effect of Sex in Systemic Psoriasis Therapy: Differences in Prescription, Effectiveness and Safety in the BIOBADADERM Prospective Cohort.
The effect of sex on systemic therapy for psoriasis has not been well studied. The aim of this study was to analyse a large multicentre Spanish cohort of 2,881 patients with psoriasi... | ADALIMUMAB, APREMILAST, CYCLOSPORINE, INFLIXIMAB, IXEKIZUMAB, METHOTREXATE, SECUKINUMAB, USTEKINUMAB | DrugsGivenReaction | CC BY-NC | 33269405 | 18,973,641 | 2021-01-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Breast disorder'. | Effect of Sex in Systemic Psoriasis Therapy: Differences in Prescription, Effectiveness and Safety in the BIOBADADERM Prospective Cohort.
The effect of sex on systemic therapy for psoriasis has not been well studied. The aim of this study was to analyse a large multicentre Spanish cohort of 2,881 patients with psoriasi... | ADALIMUMAB, APREMILAST, CYCLOSPORINE, INFLIXIMAB, IXEKIZUMAB, METHOTREXATE, SECUKINUMAB, USTEKINUMAB | DrugsGivenReaction | CC BY-NC | 33269405 | 18,973,641 | 2021-01-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cardiac disorder'. | Effect of Sex in Systemic Psoriasis Therapy: Differences in Prescription, Effectiveness and Safety in the BIOBADADERM Prospective Cohort.
The effect of sex on systemic therapy for psoriasis has not been well studied. The aim of this study was to analyse a large multicentre Spanish cohort of 2,881 patients with psoriasi... | ADALIMUMAB, APREMILAST, CYCLOSPORINE, INFLIXIMAB, IXEKIZUMAB, METHOTREXATE, SECUKINUMAB, USTEKINUMAB | DrugsGivenReaction | CC BY-NC | 33269405 | 18,973,641 | 2021-01-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Connective tissue disorder'. | Effect of Sex in Systemic Psoriasis Therapy: Differences in Prescription, Effectiveness and Safety in the BIOBADADERM Prospective Cohort.
The effect of sex on systemic therapy for psoriasis has not been well studied. The aim of this study was to analyse a large multicentre Spanish cohort of 2,881 patients with psoriasi... | ADALIMUMAB, APREMILAST, CYCLOSPORINE, INFLIXIMAB, IXEKIZUMAB, METHOTREXATE, SECUKINUMAB, USTEKINUMAB | DrugsGivenReaction | CC BY-NC | 33269405 | 18,973,641 | 2021-01-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Death'. | Effect of Sex in Systemic Psoriasis Therapy: Differences in Prescription, Effectiveness and Safety in the BIOBADADERM Prospective Cohort.
The effect of sex on systemic therapy for psoriasis has not been well studied. The aim of this study was to analyse a large multicentre Spanish cohort of 2,881 patients with psoriasi... | ADALIMUMAB, APREMILAST, CYCLOSPORINE, INFLIXIMAB, IXEKIZUMAB, METHOTREXATE, SECUKINUMAB, USTEKINUMAB | DrugsGivenReaction | CC BY-NC | 33269405 | 18,973,641 | 2021-01-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Effect of Sex in Systemic Psoriasis Therapy: Differences in Prescription, Effectiveness and Safety in the BIOBADADERM Prospective Cohort.
The effect of sex on systemic therapy for psoriasis has not been well studied. The aim of this study was to analyse a large multicentre Spanish cohort of 2,881 patients with psoriasi... | ADALIMUMAB, APREMILAST, CYCLOSPORINE, INFLIXIMAB, IXEKIZUMAB, METHOTREXATE, SECUKINUMAB, USTEKINUMAB | DrugsGivenReaction | CC BY-NC | 33269405 | 18,973,641 | 2021-01-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Ear disorder'. | Effect of Sex in Systemic Psoriasis Therapy: Differences in Prescription, Effectiveness and Safety in the BIOBADADERM Prospective Cohort.
The effect of sex on systemic therapy for psoriasis has not been well studied. The aim of this study was to analyse a large multicentre Spanish cohort of 2,881 patients with psoriasi... | ADALIMUMAB, APREMILAST, CYCLOSPORINE, INFLIXIMAB, IXEKIZUMAB, METHOTREXATE, SECUKINUMAB, USTEKINUMAB | DrugsGivenReaction | CC BY-NC | 33269405 | 18,973,641 | 2021-01-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Endocrine disorder'. | Effect of Sex in Systemic Psoriasis Therapy: Differences in Prescription, Effectiveness and Safety in the BIOBADADERM Prospective Cohort.
The effect of sex on systemic therapy for psoriasis has not been well studied. The aim of this study was to analyse a large multicentre Spanish cohort of 2,881 patients with psoriasi... | ADALIMUMAB, APREMILAST, CYCLOSPORINE, INFLIXIMAB, IXEKIZUMAB, METHOTREXATE, SECUKINUMAB, USTEKINUMAB | DrugsGivenReaction | CC BY-NC | 33269405 | 18,973,641 | 2021-01-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Eye disorder'. | Effect of Sex in Systemic Psoriasis Therapy: Differences in Prescription, Effectiveness and Safety in the BIOBADADERM Prospective Cohort.
The effect of sex on systemic therapy for psoriasis has not been well studied. The aim of this study was to analyse a large multicentre Spanish cohort of 2,881 patients with psoriasi... | ADALIMUMAB, APREMILAST, CYCLOSPORINE, INFLIXIMAB, IXEKIZUMAB, METHOTREXATE, SECUKINUMAB, USTEKINUMAB | DrugsGivenReaction | CC BY-NC | 33269405 | 18,973,641 | 2021-01-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Gastrointestinal disorder'. | Effect of Sex in Systemic Psoriasis Therapy: Differences in Prescription, Effectiveness and Safety in the BIOBADADERM Prospective Cohort.
The effect of sex on systemic therapy for psoriasis has not been well studied. The aim of this study was to analyse a large multicentre Spanish cohort of 2,881 patients with psoriasi... | ADALIMUMAB, APREMILAST, CYCLOSPORINE, INFLIXIMAB, IXEKIZUMAB, METHOTREXATE, SECUKINUMAB, USTEKINUMAB | DrugsGivenReaction | CC BY-NC | 33269405 | 18,973,641 | 2021-01-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hepatobiliary disease'. | Effect of Sex in Systemic Psoriasis Therapy: Differences in Prescription, Effectiveness and Safety in the BIOBADADERM Prospective Cohort.
The effect of sex on systemic therapy for psoriasis has not been well studied. The aim of this study was to analyse a large multicentre Spanish cohort of 2,881 patients with psoriasi... | ADALIMUMAB, APREMILAST, CYCLOSPORINE, INFLIXIMAB, IXEKIZUMAB, METHOTREXATE, SECUKINUMAB, USTEKINUMAB | DrugsGivenReaction | CC BY-NC | 33269405 | 18,973,641 | 2021-01-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Immune system disorder'. | Effect of Sex in Systemic Psoriasis Therapy: Differences in Prescription, Effectiveness and Safety in the BIOBADADERM Prospective Cohort.
The effect of sex on systemic therapy for psoriasis has not been well studied. The aim of this study was to analyse a large multicentre Spanish cohort of 2,881 patients with psoriasi... | ADALIMUMAB, APREMILAST, CYCLOSPORINE, INFLIXIMAB, IXEKIZUMAB, METHOTREXATE, SECUKINUMAB, USTEKINUMAB | DrugsGivenReaction | CC BY-NC | 33269405 | 18,973,641 | 2021-01-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Infection'. | Effect of Sex in Systemic Psoriasis Therapy: Differences in Prescription, Effectiveness and Safety in the BIOBADADERM Prospective Cohort.
The effect of sex on systemic therapy for psoriasis has not been well studied. The aim of this study was to analyse a large multicentre Spanish cohort of 2,881 patients with psoriasi... | ADALIMUMAB, APREMILAST, CYCLOSPORINE, INFLIXIMAB, IXEKIZUMAB, METHOTREXATE, SECUKINUMAB, USTEKINUMAB | DrugsGivenReaction | CC BY-NC | 33269405 | 18,973,641 | 2021-01-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Lymphatic disorder'. | Effect of Sex in Systemic Psoriasis Therapy: Differences in Prescription, Effectiveness and Safety in the BIOBADADERM Prospective Cohort.
The effect of sex on systemic therapy for psoriasis has not been well studied. The aim of this study was to analyse a large multicentre Spanish cohort of 2,881 patients with psoriasi... | ADALIMUMAB, APREMILAST, CYCLOSPORINE, INFLIXIMAB, IXEKIZUMAB, METHOTREXATE, SECUKINUMAB, USTEKINUMAB | DrugsGivenReaction | CC BY-NC | 33269405 | 18,973,641 | 2021-01-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Malnutrition'. | Effect of Sex in Systemic Psoriasis Therapy: Differences in Prescription, Effectiveness and Safety in the BIOBADADERM Prospective Cohort.
The effect of sex on systemic therapy for psoriasis has not been well studied. The aim of this study was to analyse a large multicentre Spanish cohort of 2,881 patients with psoriasi... | ADALIMUMAB, APREMILAST, CYCLOSPORINE, INFLIXIMAB, IXEKIZUMAB, METHOTREXATE, SECUKINUMAB, USTEKINUMAB | DrugsGivenReaction | CC BY-NC | 33269405 | 18,973,641 | 2021-01-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Mental disorder'. | Effect of Sex in Systemic Psoriasis Therapy: Differences in Prescription, Effectiveness and Safety in the BIOBADADERM Prospective Cohort.
The effect of sex on systemic therapy for psoriasis has not been well studied. The aim of this study was to analyse a large multicentre Spanish cohort of 2,881 patients with psoriasi... | ADALIMUMAB, APREMILAST, CYCLOSPORINE, INFLIXIMAB, IXEKIZUMAB, METHOTREXATE, SECUKINUMAB, USTEKINUMAB | DrugsGivenReaction | CC BY-NC | 33269405 | 18,973,641 | 2021-01-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Metabolic disorder'. | Effect of Sex in Systemic Psoriasis Therapy: Differences in Prescription, Effectiveness and Safety in the BIOBADADERM Prospective Cohort.
The effect of sex on systemic therapy for psoriasis has not been well studied. The aim of this study was to analyse a large multicentre Spanish cohort of 2,881 patients with psoriasi... | ADALIMUMAB, APREMILAST, CYCLOSPORINE, INFLIXIMAB, IXEKIZUMAB, METHOTREXATE, SECUKINUMAB, USTEKINUMAB | DrugsGivenReaction | CC BY-NC | 33269405 | 18,973,641 | 2021-01-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Musculoskeletal disorder'. | Effect of Sex in Systemic Psoriasis Therapy: Differences in Prescription, Effectiveness and Safety in the BIOBADADERM Prospective Cohort.
The effect of sex on systemic therapy for psoriasis has not been well studied. The aim of this study was to analyse a large multicentre Spanish cohort of 2,881 patients with psoriasi... | ADALIMUMAB, APREMILAST, CYCLOSPORINE, INFLIXIMAB, IXEKIZUMAB, METHOTREXATE, SECUKINUMAB, USTEKINUMAB | DrugsGivenReaction | CC BY-NC | 33269405 | 18,973,641 | 2021-01-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neoplasm malignant'. | Effect of Sex in Systemic Psoriasis Therapy: Differences in Prescription, Effectiveness and Safety in the BIOBADADERM Prospective Cohort.
The effect of sex on systemic therapy for psoriasis has not been well studied. The aim of this study was to analyse a large multicentre Spanish cohort of 2,881 patients with psoriasi... | ADALIMUMAB, APREMILAST, CYCLOSPORINE, INFLIXIMAB, IXEKIZUMAB, METHOTREXATE, SECUKINUMAB, USTEKINUMAB | DrugsGivenReaction | CC BY-NC | 33269405 | 18,973,641 | 2021-01-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neoplasm'. | Effect of Sex in Systemic Psoriasis Therapy: Differences in Prescription, Effectiveness and Safety in the BIOBADADERM Prospective Cohort.
The effect of sex on systemic therapy for psoriasis has not been well studied. The aim of this study was to analyse a large multicentre Spanish cohort of 2,881 patients with psoriasi... | ADALIMUMAB, APREMILAST, CYCLOSPORINE, INFLIXIMAB, IXEKIZUMAB, METHOTREXATE, SECUKINUMAB, USTEKINUMAB | DrugsGivenReaction | CC BY-NC | 33269405 | 18,973,641 | 2021-01-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Nervous system disorder'. | Effect of Sex in Systemic Psoriasis Therapy: Differences in Prescription, Effectiveness and Safety in the BIOBADADERM Prospective Cohort.
The effect of sex on systemic therapy for psoriasis has not been well studied. The aim of this study was to analyse a large multicentre Spanish cohort of 2,881 patients with psoriasi... | ADALIMUMAB, APREMILAST, CYCLOSPORINE, INFLIXIMAB, IXEKIZUMAB, METHOTREXATE, SECUKINUMAB, USTEKINUMAB | DrugsGivenReaction | CC BY-NC | 33269405 | 18,973,641 | 2021-01-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Renal disorder'. | Effect of Sex in Systemic Psoriasis Therapy: Differences in Prescription, Effectiveness and Safety in the BIOBADADERM Prospective Cohort.
The effect of sex on systemic therapy for psoriasis has not been well studied. The aim of this study was to analyse a large multicentre Spanish cohort of 2,881 patients with psoriasi... | ADALIMUMAB, APREMILAST, CYCLOSPORINE, INFLIXIMAB, IXEKIZUMAB, METHOTREXATE, SECUKINUMAB, USTEKINUMAB | DrugsGivenReaction | CC BY-NC | 33269405 | 18,973,641 | 2021-01-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Reproductive tract disorder'. | Effect of Sex in Systemic Psoriasis Therapy: Differences in Prescription, Effectiveness and Safety in the BIOBADADERM Prospective Cohort.
The effect of sex on systemic therapy for psoriasis has not been well studied. The aim of this study was to analyse a large multicentre Spanish cohort of 2,881 patients with psoriasi... | ADALIMUMAB, APREMILAST, CYCLOSPORINE, INFLIXIMAB, IXEKIZUMAB, METHOTREXATE, SECUKINUMAB, USTEKINUMAB | DrugsGivenReaction | CC BY-NC | 33269405 | 18,973,641 | 2021-01-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Respiratory disorder'. | Effect of Sex in Systemic Psoriasis Therapy: Differences in Prescription, Effectiveness and Safety in the BIOBADADERM Prospective Cohort.
The effect of sex on systemic therapy for psoriasis has not been well studied. The aim of this study was to analyse a large multicentre Spanish cohort of 2,881 patients with psoriasi... | ADALIMUMAB, APREMILAST, CYCLOSPORINE, INFLIXIMAB, IXEKIZUMAB, METHOTREXATE, SECUKINUMAB, USTEKINUMAB | DrugsGivenReaction | CC BY-NC | 33269405 | 18,973,641 | 2021-01-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Skin disorder'. | Effect of Sex in Systemic Psoriasis Therapy: Differences in Prescription, Effectiveness and Safety in the BIOBADADERM Prospective Cohort.
The effect of sex on systemic therapy for psoriasis has not been well studied. The aim of this study was to analyse a large multicentre Spanish cohort of 2,881 patients with psoriasi... | ADALIMUMAB, APREMILAST, CYCLOSPORINE, INFLIXIMAB, IXEKIZUMAB, METHOTREXATE, SECUKINUMAB, USTEKINUMAB | DrugsGivenReaction | CC BY-NC | 33269405 | 18,973,641 | 2021-01-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Social problem'. | Effect of Sex in Systemic Psoriasis Therapy: Differences in Prescription, Effectiveness and Safety in the BIOBADADERM Prospective Cohort.
The effect of sex on systemic therapy for psoriasis has not been well studied. The aim of this study was to analyse a large multicentre Spanish cohort of 2,881 patients with psoriasi... | ADALIMUMAB, APREMILAST, CYCLOSPORINE, INFLIXIMAB, IXEKIZUMAB, METHOTREXATE, SECUKINUMAB, USTEKINUMAB | DrugsGivenReaction | CC BY-NC | 33269405 | 18,973,641 | 2021-01-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Urinary tract disorder'. | Effect of Sex in Systemic Psoriasis Therapy: Differences in Prescription, Effectiveness and Safety in the BIOBADADERM Prospective Cohort.
The effect of sex on systemic therapy for psoriasis has not been well studied. The aim of this study was to analyse a large multicentre Spanish cohort of 2,881 patients with psoriasi... | ADALIMUMAB, APREMILAST, CYCLOSPORINE, INFLIXIMAB, IXEKIZUMAB, METHOTREXATE, SECUKINUMAB, USTEKINUMAB | DrugsGivenReaction | CC BY-NC | 33269405 | 18,973,641 | 2021-01-04 |
What was the outcome of reaction 'Death'? | Effect of Sex in Systemic Psoriasis Therapy: Differences in Prescription, Effectiveness and Safety in the BIOBADADERM Prospective Cohort.
The effect of sex on systemic therapy for psoriasis has not been well studied. The aim of this study was to analyse a large multicentre Spanish cohort of 2,881 patients with psoriasi... | Fatal | ReactionOutcome | CC BY-NC | 33269405 | 18,973,641 | 2021-01-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Breast cancer'. | NGS-guided precision oncology in metastatic breast and gynecological cancer: first experiences at the CCC Munich LMU.
Comprehensive genomic profiling identifying actionable molecular alterations aims to enable personalized treatment for cancer patients. The purpose of this analysis was to retrospectively assess the imp... | EVEROLIMUS, EXEMESTANE, TRASTUZUMAB | DrugsGivenReaction | CC BY | 33277683 | 19,645,107 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | NGS-guided precision oncology in metastatic breast and gynecological cancer: first experiences at the CCC Munich LMU.
Comprehensive genomic profiling identifying actionable molecular alterations aims to enable personalized treatment for cancer patients. The purpose of this analysis was to retrospectively assess the imp... | EVEROLIMUS, EXEMESTANE, TRASTUZUMAB | DrugsGivenReaction | CC BY | 33277683 | 19,645,107 | 2021-05 |
What was the outcome of reaction 'Breast cancer'? | NGS-guided precision oncology in metastatic breast and gynecological cancer: first experiences at the CCC Munich LMU.
Comprehensive genomic profiling identifying actionable molecular alterations aims to enable personalized treatment for cancer patients. The purpose of this analysis was to retrospectively assess the imp... | Fatal | ReactionOutcome | CC BY | 33277683 | 19,645,107 | 2021-05 |
What was the outcome of reaction 'Off label use'? | NGS-guided precision oncology in metastatic breast and gynecological cancer: first experiences at the CCC Munich LMU.
Comprehensive genomic profiling identifying actionable molecular alterations aims to enable personalized treatment for cancer patients. The purpose of this analysis was to retrospectively assess the imp... | Fatal | ReactionOutcome | CC BY | 33277683 | 19,645,107 | 2021-05 |
What was the administration route of drug 'TOCILIZUMAB'? | Exacerbation of Ulcerative Colitis with Tocilizumab: A Report of Two Cases, One with Takayasu Arteritis and the Other with Relapsing Polychondritis.
Tocilizumab (TCZ), a biologic that blocks the signal transduction of interleukin-6, has been used for the treatment of various autoimmune diseases. Many of these cases are... | Subcutaneous | DrugAdministrationRoute | CC BY-NC-ND | 33281154 | 18,645,469 | 2021-05-15 |
What was the dosage of drug 'TOCILIZUMAB'? | Exacerbation of Ulcerative Colitis with Tocilizumab: A Report of Two Cases, One with Takayasu Arteritis and the Other with Relapsing Polychondritis.
Tocilizumab (TCZ), a biologic that blocks the signal transduction of interleukin-6, has been used for the treatment of various autoimmune diseases. Many of these cases are... | 162 mg (milligrams). | DrugDosage | CC BY-NC-ND | 33281154 | 18,645,469 | 2021-05-15 |
What was the outcome of reaction 'Colitis ulcerative'? | Exacerbation of Ulcerative Colitis with Tocilizumab: A Report of Two Cases, One with Takayasu Arteritis and the Other with Relapsing Polychondritis.
Tocilizumab (TCZ), a biologic that blocks the signal transduction of interleukin-6, has been used for the treatment of various autoimmune diseases. Many of these cases are... | Recovering | ReactionOutcome | CC BY-NC-ND | 33281154 | 18,645,469 | 2021-05-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Femur fracture'. | Precontoured Plate Fixation for Incomplete Atypical Diaphyseal Fracture of Femur using Three-Dimensional Printing Rapid Prototyping: Two Cases Reports.
BACKGROUND
Reconstruction intramedullary nail spanning the whole length of the femur has been the gold standard treatment for complete atypical diaphyseal fractures of ... | IBANDRONIC ACID | DrugsGivenReaction | CC BY-NC-ND | 33283486 | 19,095,549 | 2021-02 |
What was the outcome of reaction 'Femur fracture'? | Precontoured Plate Fixation for Incomplete Atypical Diaphyseal Fracture of Femur using Three-Dimensional Printing Rapid Prototyping: Two Cases Reports.
BACKGROUND
Reconstruction intramedullary nail spanning the whole length of the femur has been the gold standard treatment for complete atypical diaphyseal fractures of ... | Recovering | ReactionOutcome | CC BY-NC-ND | 33283486 | 19,095,549 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease progression'. | Clinical Experience of Male Primary Choriocarcinoma at the Samsung Medical Center.
OBJECTIVE
The objective of this study was to describe and analyze the clinicopathological features of primary choriocarcinoma (PCC) observed in male patients treated at the Samsung Medical Center between 1996 and 2020.
METHODS
We revie... | CISPLATIN, DOXORUBICIN, ETOPOSIDE, IFOSFAMIDE, METHOTREXATE, PACLITAXEL, VINBLASTINE | DrugsGivenReaction | CC BY-NC | 33285049 | 20,373,268 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Respiratory failure'. | Clinical Experience of Male Primary Choriocarcinoma at the Samsung Medical Center.
OBJECTIVE
The objective of this study was to describe and analyze the clinicopathological features of primary choriocarcinoma (PCC) observed in male patients treated at the Samsung Medical Center between 1996 and 2020.
METHODS
We revie... | CISPLATIN, DOXORUBICIN, ETOPOSIDE, IFOSFAMIDE, METHOTREXATE, PACLITAXEL, VINBLASTINE | DrugsGivenReaction | CC BY-NC | 33285049 | 20,373,268 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapy partial responder'. | Clinical Experience of Male Primary Choriocarcinoma at the Samsung Medical Center.
OBJECTIVE
The objective of this study was to describe and analyze the clinicopathological features of primary choriocarcinoma (PCC) observed in male patients treated at the Samsung Medical Center between 1996 and 2020.
METHODS
We revie... | BLEOMYCIN SULFATE, CISPLATIN, CYCLOPHOSPHAMIDE, DOXORUBICIN, ETOPOSIDE, IFOSFAMIDE, PACLITAXEL | DrugsGivenReaction | CC BY-NC | 33285049 | 20,373,510 | 2021-07 |
What was the dosage of drug 'BLEOMYCIN SULFATE'? | Clinical Experience of Male Primary Choriocarcinoma at the Samsung Medical Center.
OBJECTIVE
The objective of this study was to describe and analyze the clinicopathological features of primary choriocarcinoma (PCC) observed in male patients treated at the Samsung Medical Center between 1996 and 2020.
METHODS
We revie... | 3 CYCLES | DrugDosageText | CC BY-NC | 33285049 | 20,373,510 | 2021-07 |
What was the dosage of drug 'CYCLOPHOSPHAMIDE'? | Clinical Experience of Male Primary Choriocarcinoma at the Samsung Medical Center.
OBJECTIVE
The objective of this study was to describe and analyze the clinicopathological features of primary choriocarcinoma (PCC) observed in male patients treated at the Samsung Medical Center between 1996 and 2020.
METHODS
We revie... | 2 CYCLES | DrugDosageText | CC BY-NC | 33285049 | 20,373,510 | 2021-07 |
What was the dosage of drug 'DOXORUBICIN'? | Clinical Experience of Male Primary Choriocarcinoma at the Samsung Medical Center.
OBJECTIVE
The objective of this study was to describe and analyze the clinicopathological features of primary choriocarcinoma (PCC) observed in male patients treated at the Samsung Medical Center between 1996 and 2020.
METHODS
We revie... | 2 CYCLES | DrugDosageText | CC BY-NC | 33285049 | 20,373,510 | 2021-07 |
What was the dosage of drug 'IFOSFAMIDE'? | Clinical Experience of Male Primary Choriocarcinoma at the Samsung Medical Center.
OBJECTIVE
The objective of this study was to describe and analyze the clinicopathological features of primary choriocarcinoma (PCC) observed in male patients treated at the Samsung Medical Center between 1996 and 2020.
METHODS
We revie... | 3 CYCLES | DrugDosageText | CC BY-NC | 33285049 | 20,373,510 | 2021-07 |
What was the dosage of drug 'PACLITAXEL'? | Clinical Experience of Male Primary Choriocarcinoma at the Samsung Medical Center.
OBJECTIVE
The objective of this study was to describe and analyze the clinicopathological features of primary choriocarcinoma (PCC) observed in male patients treated at the Samsung Medical Center between 1996 and 2020.
METHODS
We revie... | 3 CYCLES | DrugDosageText | CC BY-NC | 33285049 | 20,373,510 | 2021-07 |
What was the outcome of reaction 'Disease progression'? | Clinical Experience of Male Primary Choriocarcinoma at the Samsung Medical Center.
OBJECTIVE
The objective of this study was to describe and analyze the clinicopathological features of primary choriocarcinoma (PCC) observed in male patients treated at the Samsung Medical Center between 1996 and 2020.
METHODS
We revie... | Fatal | ReactionOutcome | CC BY-NC | 33285049 | 20,373,268 | 2021-07 |
What was the outcome of reaction 'Drug resistance'? | Clinical Experience of Male Primary Choriocarcinoma at the Samsung Medical Center.
OBJECTIVE
The objective of this study was to describe and analyze the clinicopathological features of primary choriocarcinoma (PCC) observed in male patients treated at the Samsung Medical Center between 1996 and 2020.
METHODS
We revie... | Fatal | ReactionOutcome | CC BY-NC | 33285049 | 20,373,274 | 2021-07 |
What was the outcome of reaction 'Respiratory failure'? | Clinical Experience of Male Primary Choriocarcinoma at the Samsung Medical Center.
OBJECTIVE
The objective of this study was to describe and analyze the clinicopathological features of primary choriocarcinoma (PCC) observed in male patients treated at the Samsung Medical Center between 1996 and 2020.
METHODS
We revie... | Fatal | ReactionOutcome | CC BY-NC | 33285049 | 20,373,268 | 2021-07 |
What was the outcome of reaction 'Treatment failure'? | Clinical Experience of Male Primary Choriocarcinoma at the Samsung Medical Center.
OBJECTIVE
The objective of this study was to describe and analyze the clinicopathological features of primary choriocarcinoma (PCC) observed in male patients treated at the Samsung Medical Center between 1996 and 2020.
METHODS
We revie... | Fatal | ReactionOutcome | CC BY-NC | 33285049 | 20,373,274 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Abdominal pain upper'. | Midostaurin after allogeneic stem cell transplant in patients with FLT3-internal tandem duplication-positive acute myeloid leukemia.
We evaluated standard-of-care (SOC) treatment with or without midostaurin to prevent relapse following allogeneic hematopoietic stem cell transplant (alloHSCT) in patients with acute myel... | MAGNESIUM SULFATE, MIDOSTAURIN, SULFAMETHOXAZOLE\TRIMETHOPRIM | DrugsGivenReaction | CC BY | 33288862 | 18,658,791 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Abdominal pain'. | Midostaurin after allogeneic stem cell transplant in patients with FLT3-internal tandem duplication-positive acute myeloid leukemia.
We evaluated standard-of-care (SOC) treatment with or without midostaurin to prevent relapse following allogeneic hematopoietic stem cell transplant (alloHSCT) in patients with acute myel... | MAGNESIUM SULFATE, MIDOSTAURIN, SULFAMETHOXAZOLE\TRIMETHOPRIM | DrugsGivenReaction | CC BY | 33288862 | 18,658,791 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Appendicitis'. | Midostaurin after allogeneic stem cell transplant in patients with FLT3-internal tandem duplication-positive acute myeloid leukemia.
We evaluated standard-of-care (SOC) treatment with or without midostaurin to prevent relapse following allogeneic hematopoietic stem cell transplant (alloHSCT) in patients with acute myel... | MAGNESIUM SULFATE, MIDOSTAURIN, SULFAMETHOXAZOLE\TRIMETHOPRIM | DrugsGivenReaction | CC BY | 33288862 | 18,658,791 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Chills'. | Midostaurin after allogeneic stem cell transplant in patients with FLT3-internal tandem duplication-positive acute myeloid leukemia.
We evaluated standard-of-care (SOC) treatment with or without midostaurin to prevent relapse following allogeneic hematopoietic stem cell transplant (alloHSCT) in patients with acute myel... | MAGNESIUM SULFATE, MIDOSTAURIN, SULFAMETHOXAZOLE\TRIMETHOPRIM | DrugsGivenReaction | CC BY | 33288862 | 18,658,791 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Diarrhoea'. | Midostaurin after allogeneic stem cell transplant in patients with FLT3-internal tandem duplication-positive acute myeloid leukemia.
We evaluated standard-of-care (SOC) treatment with or without midostaurin to prevent relapse following allogeneic hematopoietic stem cell transplant (alloHSCT) in patients with acute myel... | MAGNESIUM SULFATE, MIDOSTAURIN, SULFAMETHOXAZOLE\TRIMETHOPRIM | DrugsGivenReaction | CC BY | 33288862 | 18,658,791 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Nausea'. | Midostaurin after allogeneic stem cell transplant in patients with FLT3-internal tandem duplication-positive acute myeloid leukemia.
We evaluated standard-of-care (SOC) treatment with or without midostaurin to prevent relapse following allogeneic hematopoietic stem cell transplant (alloHSCT) in patients with acute myel... | MAGNESIUM SULFATE, MIDOSTAURIN, SULFAMETHOXAZOLE\TRIMETHOPRIM | DrugsGivenReaction | CC BY | 33288862 | 18,658,791 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Vomiting'. | Midostaurin after allogeneic stem cell transplant in patients with FLT3-internal tandem duplication-positive acute myeloid leukemia.
We evaluated standard-of-care (SOC) treatment with or without midostaurin to prevent relapse following allogeneic hematopoietic stem cell transplant (alloHSCT) in patients with acute myel... | MAGNESIUM SULFATE, MIDOSTAURIN, SULFAMETHOXAZOLE\TRIMETHOPRIM | DrugsGivenReaction | CC BY | 33288862 | 18,658,791 | 2021-05 |
What is the weight of the patient? | Midostaurin after allogeneic stem cell transplant in patients with FLT3-internal tandem duplication-positive acute myeloid leukemia.
We evaluated standard-of-care (SOC) treatment with or without midostaurin to prevent relapse following allogeneic hematopoietic stem cell transplant (alloHSCT) in patients with acute myel... | 100.68 kg. | Weight | CC BY | 33288862 | 18,658,791 | 2021-05 |
What was the administration route of drug 'MIDOSTAURIN'? | Midostaurin after allogeneic stem cell transplant in patients with FLT3-internal tandem duplication-positive acute myeloid leukemia.
We evaluated standard-of-care (SOC) treatment with or without midostaurin to prevent relapse following allogeneic hematopoietic stem cell transplant (alloHSCT) in patients with acute myel... | Oral | DrugAdministrationRoute | CC BY | 33288862 | 18,658,791 | 2021-05 |
What was the outcome of reaction 'Abdominal pain'? | Midostaurin after allogeneic stem cell transplant in patients with FLT3-internal tandem duplication-positive acute myeloid leukemia.
We evaluated standard-of-care (SOC) treatment with or without midostaurin to prevent relapse following allogeneic hematopoietic stem cell transplant (alloHSCT) in patients with acute myel... | Recovered | ReactionOutcome | CC BY | 33288862 | 18,658,791 | 2021-05 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.